A detailed history of Israel Englander (Millennium Management LLC) transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 100,000 shares of RXRX stock, worth $697,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,000
Previous 11,077 802.77%
Holding current value
$697,000
Previous $110,000 581.82%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$9.13 - $15.52 $101,133 - $171,915
11,077 New
11,077 $110,000
Q1 2023

May 15, 2023

SELL
$6.42 - $9.64 $313,058 - $470,075
-48,763 Reduced 7.01%
646,610 $4.31 Million
Q4 2022

Feb 14, 2023

BUY
$7.16 - $12.7 $3.26 Million - $5.79 Million
455,977 Added 190.47%
695,373 $5.36 Million
Q3 2022

Nov 14, 2022

SELL
$7.83 - $13.6 $1.13 Million - $1.96 Million
-143,778 Reduced 37.52%
239,396 $2.55 Million

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.26B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.